Contrapill Kit

البلد: الهند

اللغة: الإنجليزية

المصدر: Central Drugs Standard Control Organization

العنصر النشط:

Mifepristone, Misoprostol

متاح من:

Cadila Pharma

جرعة:

mifopristone 200mg, misoprostol 200 μg

الشكل الصيدلاني:

Tablet

تركيب:

1 tablet of mifepristone 200, 4 tablets of misoprostol 200 mcg

طريقة التعاطي:

Oral

الوحدات في الحزمة:

1 KIT (1+4)

المجموعة العلاجية:

Hormones, Contraceptives and Related Drugs

الخصائص العلاجية:

Medical termination of pregnancy of up to 49 days, cervical dilatation prior to surgical termination of pregnancy in the first trimester, therapeutic termination of pregnancy for medical reasons beyond the first trimester, labor induction in case of fetal death in utero.

خصائص المنتج

MIFEPRISTONE + MISOPROSTOL
Pregnancy Category-X
Schedule H
INDICATIONS 
Medical termination of pregnancy of up to 49 days,
cervical dilatation prior to surgical termination of 
pregnancy in the first trimester, therapeutic termination of
pregnancy for medical reasons beyond the 
first trimester, labor induction in case of fetal death
in utero.
AVAILABILITY 
Tablet KIT mifopristone 200mg, misoprostol 200 μg.
DOSE 
Mifepristone 200 mg orally followed 1 to 3 days latter by
misoprostol 800 μg vaginally.
Patients should return for follow up visit after approximately 14
days after administration of 
mifepristone.
CONTRAINDICATIONS
Hypersensitivity to Mifepristone, Misoprostol or
other prostaglandin; confirmed or suspected ectopic 
pregnancy; chronic adrenal failure; haemorrhagic disorders or
concurrent anticoagulant therapy; 
inherited porphyria.
PRECAUTIONS
IUD in
place; asthma, chronic obstructive pulmonary disease; alcoholism; prosthetic heart valve; 
infective endocarditis;, pregnancy.
ADVERSE EFFECTS
Abdominal pain, diarrhoea, nausea, vomiting; fever, chills,
uterine cramping; vaginal bleeding or 
spotting; Pelvic inflammatory disease.
INTERACTIONS
Dexamethasone: decreased serum levels of mifepristone
-------------------------
DOCUMENT OUTLINE * Mifepristone + Misoprostol [/In_18294_SPC.html#1] * Indications [/In_18294_SPC.html#1] * Availability [/In_18294_SPC.html#1] * Dose [/In_18294_SPC.html#1] * Contraindications [/In_18294_SPC.html#1] * Precautions [/In_18294_SPC.html#1] * Adverse Effects [/In_18294_SPC.html#1] * Interactions [/In_18294_SPC.html#1]